TFIIIC220 Activators
TFIIIC220 Activators are a class of compounds that selectively enhance the activity of the transcription factor complex subunit TFIIIC220, a critical component of the RNA polymerase III transcription machinery. These activators function through various cellular mechanisms to increase the transcriptional efficacy of genes under the direct control of RNA polymerase III. One mode of action involves the stabilization of TFIIIC220's binding to the B-box elements of DNA, an essential step for the assembly of the transcription complex. This is achieved either by altering the conformation of TFIIIC220 to favor DNA binding or by modulating the local chromatin structure to make the B-box elements more accessible. Some activators may also work by influencing the post-translational modifications of TFIIIC220, such as phosphorylation or acetylation, thereby enhancing its interaction with other transcriptional co-factors and promoting a more robust assembly of the transcription complex.
In addition to DNA-binding stabilization, TFIIIC220 Activators can also indirectly enhance TFIIIC220 activity by modulating the levels of various co-activator proteins or transcriptional repressors. These compounds may either inhibit the negative regulators of TFIIIC220 or upregulate proteins that act synergistically with TFIIIC220 to potentiate RNA polymerase III transcription. By adjusting the intracellular concentrations of these regulatory factors, TFIIIC220 Activators can fine-tune the transcriptional output of genes that rely on TFIIIC220 for their expression. Furthermore, some activators may act by altering signaling pathways that impinge on the TFIIIC220 functions, such as pathways that influence nucleocytoplasmic transport or the availability of transcriptional machinery components in the nucleus. Overall, TFIIIC220 Activators work through a dynamic interplay of direct and indirect mechanisms to ensure the optimal activity of TFIIIC220, thereby fostering the precise transcriptional control required for the cellular homeostasis and function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP enhances the activity of TFIIIC220 by promoting the assembly and stability of the transcription complex it is part of. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cAMP, a cAMP analog, directly stimulates cAMP-dependent pathways, which can enhance TFIIIC220 function in the transcription initiation complex. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, increases cAMP levels, thereby potentially enhancing TFIIIC220 activity as part of the transcription initiation process. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4, leading to an increase in cAMP levels, which may enhance the function of TFIIIC220 in its role in transcription regulation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX, a nonspecific inhibitor of phosphodiesterases, increases cAMP levels, which may indirectly enhance the functional activity of TFIIIC220 in the transcription machinery. | ||||||
PGE1 (Prostaglandin E1) | 745-65-3 | sc-201223 sc-201223A | 1 mg 10 mg | $31.00 $145.00 | 16 | |
PGE1 elevates cAMP levels, which may enhance TFIIIC220's role in the transcription complex formation by influencing transcription factor binding. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine, through its action on adrenergic receptors, increases intracellular cAMP, which can enhance the function of TFIIIC220 in the transcription complex assembly. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine, through the H2 receptor, can increase cAMP levels, which may lead to enhanced activity of TFIIIC220 in its role in RNA polymerase III recruitment. | ||||||
Cilostazol | 73963-72-1 | sc-201182 sc-201182A | 10 mg 50 mg | $109.00 $322.00 | 3 | |
Cilostazol increases cAMP by inhibiting phosphodiesterase III, which could enhance the functional activity of TFIIIC220 in transcription initiation. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
Milrinone selectively inhibits phosphodiesterase III, leading to increased cAMP and potentially enhanced TFIIIC220 activity in transcription assembly. | ||||||